Back to Search Start Over

Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria

Authors :
Jutta Marfurt
Rintis Noviyanti
Daniel A. Lampah
Thor G. Theander
Freya J. I. Fowkes
Thomas Lavstsen
Graham Brown
Leily Trianty
Takafumi Tsuboi
Louise Turner
Peter Siba
Boni F. Sebayang
Nicholas M. Anstey
Zhi-Ping Feng
Fransisca Sumardy
Michael F. Duffy
Stephen J. Rogerson
Anthony T. Papenfuss
Eizo Takashima
Ric N. Price
Source :
Duffy, M F, Noviyanti, R, Tsuboi, T, Feng, Z-P, Trianty, L, Sebayang, B F, Takashima, E, Sumardy, F, Lampah, D A, Turner, L, Lavstsen, T, Fowkes, F J I, Siba, P, Rogerson, S J, Theander, T G, Marfurt, J, Price, R N, Anstey, N M, Brown, G V & Papenfuss, A T 2016, ' Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria ', Malaria Journal, vol. 15, 258 . https://doi.org/10.1186/s12936-016-1296-4, Malaria Journal
Publication Year :
2016

Abstract

Background Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants are encoded by var genes and mediate pathogenic cytoadhesion and antigenic variation in malaria. PfEMP1s can be broadly divided into three principal groups (A, B and C) and they contain conserved arrangements of functional domains called domain cassettes. Despite their tremendous diversity there is compelling evidence that a restricted subset of PfEMP1s is expressed in severe disease. In this study antibodies from patients with severe and uncomplicated malaria were compared for differences in reactivity with a range of PfEMP1s to determine whether antibodies to particular PfEMP1 domains were associated with severe or uncomplicated malaria. Methods Parts of expressed var genes in a severe malaria patient were identified by RNAseq and several of these partial PfEMP1 domains were expressed together with others from laboratory isolates. Antibodies from Papuan patients to these parts of multiple PfEMP1 proteins were measured. Results Patients with uncomplicated malaria were more likely to have antibodies that recognized PfEMP1 of Group C type and recognized a broader repertoire of group A and B PfEMP1s than patients with severe malaria. Conclusion These data suggest that exposure to a broad range of group A and B PfEMP1s is associated with protection from severe disease in Papua, Indonesia. Electronic supplementary material The online version of this article (doi:10.1186/s12936-016-1296-4) contains supplementary material, which is available to authorized users.

Details

Language :
English
Database :
OpenAIRE
Journal :
Duffy, M F, Noviyanti, R, Tsuboi, T, Feng, Z-P, Trianty, L, Sebayang, B F, Takashima, E, Sumardy, F, Lampah, D A, Turner, L, Lavstsen, T, Fowkes, F J I, Siba, P, Rogerson, S J, Theander, T G, Marfurt, J, Price, R N, Anstey, N M, Brown, G V & Papenfuss, A T 2016, ' Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria ', Malaria Journal, vol. 15, 258 . https://doi.org/10.1186/s12936-016-1296-4, Malaria Journal
Accession number :
edsair.doi.dedup.....18a0aaa39c7501bd0386dbb1306f2a29
Full Text :
https://doi.org/10.1186/s12936-016-1296-4